Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of Dose Conversion From Vicodin® to Buprenorphine Transdermal System (Butrans™) in Subjects With OA Pain

ClinicalTrials.gov ID: NCT00312572

Public ClinicalTrials.gov record NCT00312572. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 1:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind Study Evaluating the Dose Conversion From Vicodin® to Buprenorphine Transdermal System (BTDS) in Subjects With Osteoarthritis (OA) Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to evaluate the safety and efficacy of dose conversion from hydrocodone/ acetaminophen (Vicodin®) to the buprenorphine transdermal system (Butrans™) in subjects with osteoarthritis pain of the hip or knee. The double-blind treatment intervention duration is 2 weeks during which time supplemental analgesic medication will be allowed.

Study identification

NCT ID
NCT00312572
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Purdue Pharma LP
Industry
Enrollment
204 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
40 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2003
Primary completion
Jun 30, 2004
Completion
Jun 30, 2004
Last update posted
Sep 2, 2012

2003 – 2004

United States locations

U.S. sites
36
U.S. states
20
U.S. cities
35
Facility City State ZIP Site status
Southern Drug Research Birmingham Alabama 35007
Redpoint Research Phoenix Arizona 85029
Advanced Clinical Therapeutics Tucson Arizona 85712
Tucson Orthopedic Institute Tucson Arizona 85712
Hot Springs Mercy Pain Clinic Hot Springs Arkansas 71913
Private Practice Pine Bluff Arkansas 71603
Advanced Clinical Research Institute Anaheim California 92801
Lovelace Scientific Resources Beverly Hills California 90211
Southbay Pharma Research Buena Park California 90620
Community Medical Providers Clovis California 93611
Kaiser Permanente Escondido California 92025
Univ. of Southern California Santa Monica California 90404
Arthritis Center of CT Waterbury Connecticut 06708
Lifespan Research Foundation, Inc. Miami Florida 33186
Miami Beach Anesthesiology Associates Miami Beach Florida 33140
Neuro Science and Spine Assoc. Naples Florida 34102
West Broward Rheumatology Association, Inc. Tamarac Florida 33321
Intermountain Orthopaedics Boise Idaho 83702
University of Kansas Medical Center Kansas City Kansas 66160
Bluegrass Orthopaedics Lexington Kentucky 40509
Commonwealth Biomedical Research, LLC Madisonville Kentucky 42431
Dolby Providers, Inc. New Orleans Louisiana 70128
Clinical Pharmacology Study Group Worcester Massachusetts 01610
Westside Family Medical Center Kalamazoo Michigan 49009
PCM Medical Services Lansing Michigan 48917
HealthCare Research LLC St Louis Missouri 63141
Northeast Pain Research Center Barrington New Hampshire 03825
The Arthritis Clinic and Carolina Bone and Joint Charlotte North Carolina 28210
Dayton Primary and Urgent Care Dayton Ohio 45402
The Medford Medical Clinic Medford Oregon 97504
The Arthritis and Osteoporosis Center Orangeburg South Carolina 29118
CEDRA Clinical Research, Austin Texas 78759
Renaissance Clinical Research & Hypertension Clinic Dallas Texas 75235
Spine Care Southwest. Houston Texas 77074
KRK Medical Research Richardson Texas 75080
Monroe Medical Foundation Monroe Wisconsin 53566

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00312572, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 2, 2012 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00312572 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →